Excessive anxiety in IBD patients is unnecessary for COVID-19

[1]  C. Eastin,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The Journal of Emergency Medicine.

[2]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[3]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[4]  D. Heymann,et al.  COVID-19: what is next for public health? , 2020, The Lancet.

[5]  Xingyang Xue,et al.  Diarrhea may be underestimated: a missing link in 2019 novel coronavirus , 2020, medRxiv.

[6]  Christian Drosten,et al.  The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells , 2020, bioRxiv.

[7]  Zeyu Sun,et al.  Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD38 in Inflammatory Bowel Disease , 2019, BioMed research international.

[8]  Zeyu Sun,et al.  Quantitative Proteomic Analysis Reveals the Deregulation of Nicotinamide Adenine Dinucleotide Metabolism and CD 38 in Inflammatory Bowel Disease , 2019 .

[9]  C. Hewitt,et al.  Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II. , 2018, Inflammatory bowel diseases.

[10]  C. Hewitt,et al.  Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I. , 2018, Inflammatory bowel diseases.

[11]  R. von Känel,et al.  Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.